2018 Innovation in Medical Cannabis Therapies Symposium

Please scroll down the page for event details

 

Where: The Keeping Memory Alive Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health

 

Address: 888 W Bonneville Ave, Las Vegas, NV 89106

 

When: Friday, Nov. 9th, 2018

 

Time: 9:00am to 5:00pm

 

INNOVATION IN MEDICAL CANNABIS THERAPIES: GB Sciences presents an exciting range of innovations necessary for plant-based medical cannabis therapies to become available through main stream channels.

 

Fee: Free to attend. Registration required.

Click here to register and print tickets on EventBrite

Contact Charlie Agar at charlie@gbsciences.com with questions

Event Breakdown — Nov. 9, 9 am to 5 pm

Full List of Symposium Speakers and Bios

CLICK HERE for speaker biographies and information about participants in this year’s symposium

9:35am to 10:15am — PATIENT NEEDS: A Physician-Patient-Caregiver Dialogue

  • What aspects are working in state-run “safe access” programs for patients & caregivers?
  • What is missing? How could medical cannabis products be improved?
  • How could the system be modified to ensure patient’s medical needs are met?

Dr. Zoltan Mari (Cleveland Clinic)

Parkinson’s patient spokesperson and their caregiver

Jamilliah Ali-Raman (CEO, Friends of Parkinson’s)

Meredith Patterson (RN)

11:20am to 12:00pm — CULTIVATION: THE PLANT AS A MEDICINE

  • For many patients, dried flower is their medicine (sleeping, appetite, anti-anxiety, etc.)
  • What combination of techniques and technologies help to ensure safety and consistency from batch to batch?
  • What can be done to improve upon the current industry standards?

Dr. Philip Elzer (Executive Assoc. Dean, LSU Ag Center)

Dr. Ulrich Reimann-Philipp (Lead Botanist, GB Sciences Louisiana)

Brent Perkins (President & COO, Scynce LED)

Dani Fontaine (Colorado Hemp Project)

Steve Joyner (Quantum Shop)

2:35pm to 3:15pm — CLINICAL TRIALS: Challenges & Opportunities

  • Challenges/Opportunities through the US FDA versus International Clinical Trials
  • US FDA Process = FDA, DEA, and NIDA; Sole Source of Medical Cannabis from Ole Miss
  • US Trials done under State Cannabis Programs versus Federal FDA-Registration (Pros/Cons)

Dr. Carlos Rios-Bedoya (McLaren Health)

Dr. Ziva Cooper (Columbia University)

Dr. Michael Murphy (Founder, World Wide Clinical)

Dr. Amrit Seetharam (CurAccel)

3:35pm to 4:05pm — LEGISLATIVE: Need for industry involvement in driving positive change.

  • What areas could be improved, potentially state-by-state, to enhance the effectiveness of Cannabis Research and legitimization of Cannabis as Medicine?
  • Challenges/Opportunities through the US FDA versus International Clinical Trials
  • US FDA Process = FDA, DEA, and NIDA; Sole Source of Medical Cannabis from Ole Miss
  • US Trials done under State Cannabis Programs versus Federal FDA-Registration (Pros/Cons)

Elizabeth Ashford (Founder, Ceres Strategies)

Richard S. “Tick” Segerblom (Nevada State Senator)

John Davis (President, GB Sciences Louisiana)

Sandra Tiffany (Owner, GWGA, LLC and former Nevada State Senator)

4:45pm to 5:00pm TAKE-AWAYS FROM THE AUDIENCE: Live Feedback from This Event

Moderated by Dr. Michael Farley, Valor Management, S.A.